Daily Briefing, 2026-06-22 | Medicaid Monitor

The complete record

9 stories, Monday, June 22, 2026

Federal Policy

White House Proposal Threatens Federal Funding for Health Equity Research

A new White House proposal could disqualify significant portions of health disparities research from federal funding eligibility. Health equity researchers characterize this as potentially the most serious threat to their field's future. The proposal would subject health equity studies to heightened scrutiny in federal grant review processes. The change would affect how agencies like NIH and AHRQ evaluate research focused on racial, ethnic, and socioeconomic health disparities.

Why it mattersMedicaid MCOs rely on federally-funded health equity research to design targeted interventions for populations with disparities in maternal health, behavioral health, and chronic disease outcomes required under managed care contracts.

USSTAT News7:31 AM MT

Managed Care · Maternal · Behavioral Health

Congressional Democrats Push to Repeal CMS WISeR Model

Congressional Democrats have introduced legislation to repeal the Transforming Maternal Health (TMH) Model, commonly known as WISeR (Women in States Earning Rewards). The mandatory payment model, which ties Medicaid reimbursement to quality metrics for maternal health services, has faced criticism since its launch. Policy experts say the repeal effort's success remains uncertain given the current political landscape. If repealed, states and managed care organizations participating in the model would see changes to their maternal health payment structures and quality reporting requirements.

Why it mattersMedicaid managed care organizations in WISeR states face potential operational and payment structure changes if the model is repealed, affecting maternal health quality metric reporting and value-based payment arrangements.

USMedCity News7:30 AM MT

Maternal · Managed Care

Managed Care

1 storyManaged Care section →

Health Plans Urged to Maintain Integrated Pharmacy Benefits Over Disaggregation Models

Industry commentary argues that health plans should retain integrated pharmacy benefit management rather than disaggregate services to separate PBMs or carve-out arrangements. The piece contends integrated models provide better coordination between medical and pharmacy benefits, improved utilization management, and stronger cost control compared to disaggregated approaches. No specific policy change or implementation timeline is involved; this represents strategic guidance for plan decision-making. For Medicaid MCOs facing increasing pharmacy costs and state pressure on benefit design, the integration versus disaggregation question affects contract performance, quality metrics, and administrative complexity.

Why it mattersMedicaid MCOs evaluating pharmacy benefit structures must weigh integration advantages against state requirements for transparency and potential carve-out mandates that could force disaggregation.

USHealthcare Dive7:31 AM MT

Pharmacy · Managed Care

State Policy

3 storiesState Policy section →

Advocacy Group Recommends Using State Advisory Councils to Track Work Requirement Implementation

The National Health Law Program published guidance recommending that state advocates use Medicaid Advisory Committees and Beneficiary Advisory Councils to monitor implementation of work requirements mandated under recent federal legislation. The organization cites the rapid timeline states face to implement these changes as creating monitoring challenges. The guidance aims to help advocates track how states operationalize the new requirements through existing advisory body structures. While the article provides advocacy strategy recommendations, it does not detail specific work requirement provisions, state implementation timelines, or federal enforcement mechanisms.

Why it mattersManaged care organizations contracted with states implementing work requirements will need to understand how state advisory bodies may influence operational details around eligibility verification, disenrollment processes, and member communications during the transition period.

USNational Health Law1:30 PM MT

Managed Care

Michigan Medicaid Expansion Linked to Better Health Outcomes, Financial Stability

A University of Michigan study found that the Healthy Michigan Plan improved health care access, health outcomes, and financial stability for low-income adults enrolled in the state's Medicaid expansion program. The findings arrive as Congress prepares to implement new Medicaid work requirements starting January 2027, which will require many expansion enrollees nationwide to document employment or other qualifying activities. The study provides evidence of expansion's impact as policymakers debate work requirement policies.

Why it mattersThis research provides data on expansion outcomes as managed care organizations prepare for work requirement compliance monitoring and potential enrollment changes under the 2027 federal mandate.

MImichiganadvance.com1:30 PM MT

Managed Care · Finance

Ohio projects 51,000 job losses, $5.3B economic impact from Medicaid cuts by 2029

A new analysis projects Ohio will lose 51,000 jobs and $5.3 billion in economic activity by 2029 due to Medicaid and food assistance cuts enacted in 2025 federal spending legislation, combined with the expiration of Affordable Care Act subsidies. The projections reflect the full phase-in of these policy changes over the next several years. The analysis highlights state-level economic consequences of federal budget decisions affecting health coverage programs.

Why it mattersState-level economic projections of Medicaid cuts signal potential enrollment declines, budget pressures, and reduced managed care capitation payments that MCOs must plan for in long-term contracting and network adequacy strategies.

OHohiocapitaljournal.com7:30 AM MT

Managed Care · Finance

Legal

1 storyLegal section →

DOJ Intensifies Medicaid Fraud Enforcement Under Trump Administration

The Trump Administration has significantly increased enforcement focus on waste, fraud, and abuse in Medicaid over the past six months, with the Department of Justice prioritizing False Claims Act cases against Medicaid providers and managed care organizations. This heightened scrutiny follows longstanding federal efforts to recover improper Medicaid payments but marks a notable acceleration in enforcement activity. The increased DOJ attention raises compliance and financial risk for Medicaid managed care plans, particularly around billing accuracy, utilization management, and encounter data reporting. Plans should expect more qui tam investigations and potential enforcement actions.

Why it mattersHeightened DOJ enforcement increases financial liability and qui tam lawsuit risk for MCOs with billing, coding, or encounter data vulnerabilities.

USFoley1:30 PM MT

Managed Care · Finance

Industry

2 storiesIndustry section →

Meta-Analysis Compares Weight Loss Efficacy Across Tirzepatide, Semaglutide, and Liraglutide

A new meta-analysis compared weight loss outcomes for three GLP-1 receptor agonists: tirzepatide (Zepbound, Mounjaro), semaglutide (Wegovy, Ozempic), and liraglutide (Saxenda, Victoza). The study evaluated clinical efficacy data across the three drug classes to determine comparative effectiveness for weight management. The findings provide evidence that could inform prior authorization criteria, formulary placement, and medical policy for obesity treatment in Medicaid managed care plans. Many state Medicaid programs have restricted or excluded coverage of anti-obesity medications due to cost, making comparative effectiveness data particularly relevant for coverage and utilization management decisions.

Why it mattersComparative effectiveness data on GLP-1 medications directly impacts formulary design, prior authorization protocols, and medical policy for obesity treatment coverage in Medicaid managed care plans facing mounting utilization and cost pressure.

USThe Hill7:31 AM MT

Pharmacy · Managed Care

FDA Panel Recommends Moderna mRNA Flu Vaccine for Adults 50 and Older

An FDA advisory panel recommended approval of Moderna's mFlusiva, the first mRNA-based influenza vaccine, for adults ages 50-64 and those 65 and older under specific conditions. In late-stage trials, the vaccine demonstrated 27% greater effectiveness compared to standard flu shots. The panel's recommendation followed a June 18 meeting where FDA officials reviewed the clinical data. Final FDA approval would mark the first mRNA flu vaccine on the market, potentially expanding vaccine options for Medicaid managed care plans covering adult populations.

Why it mattersA new mRNA flu vaccine with higher efficacy could affect MCO vaccine procurement strategies, pharmacy benefit management, and HEDIS flu vaccination rates for Medicare-Medicaid dual eligibles and adult Medicaid populations.

USBecker's1:30 PM MT

Managed Care · Pharmacy